ChemMedChem, volume 16, issue 1, pages 65-80

Therapeutic Strategies To Counteract Antibiotic Resistance in MRSA Biofilm‐Associated Infections

Cascioferro Stella 1
Carbone Daniela 1
Parrino Barbara 1
Pecoraro Camilla 1
Giovannetti Elisa 2, 3
Cirrincione Girolamo 1
Diana Patrizia 1
2
 
Department of Medical Oncology Cancer Center Amsterdam VU University Medical Center (VUmc) De Boelelaan 1117 1081HV Amsterdam The Netherlands
3
 
Cancer Pharmacology Lab, AIRC Start Up Fondazione Pisana per la Scienza Via Ferruccio Giovannini 13 56017, San Giuliano Terme Pisa Italy
Publication typeJournal Article
Publication date2020-11-06
Journal: ChemMedChem
Quartile SCImago
Q1
Quartile WOS
Q2
Impact factor3.4
ISSN18607179, 18607187
Organic Chemistry
Drug Discovery
Biochemistry
Pharmacology
Molecular Medicine
General Pharmacology, Toxicology and Pharmaceutics
Abstract
Methicillin‐resistant Staphylococcus aureus (MRSA) has emerged as one of the leading causes of persistent human infections. This pathogen is widespread and is able to colonize asymptomatically about a third of the population, causing moderate to severe infections. It is currently considered the most common cause of nosocomial infections and one of the main causes of death in hospitalized patients. Due to its high morbidity and mortality rate and its ability to resist most antibiotics on the market, it has been termed a “superbug”. Its ability to form biofilms on biotic and abiotic surfaces seems to be the primarily means of MRSA antibiotic resistance and pervasiveness. Importantly, more than 80 % of bacterial infections are biofilm‐mediated. Biofilm formation on indwelling catheters, prosthetic devices and implants is recognized as the cause of serious chronic infections in hospital environments. In this review we discuss the most relevant literature of the last five years concerning the development of synthetic small molecules able to inhibit biofilm formation or to eradicate or disperse pre‐formed biofilms in the fight against MRSA diseases. The aim is to provide guidelines for the development of new anti‐virulence strategies based on the knowledge so far acquired, and, to identify the main flaws of this research field, which have hindered the generation of new market‐approved anti‐MRSA drugs that are able to act against biofilm‐associated infections

Citations by journals

1
2
3
4
5
6
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 6, 6.9%
International Journal of Molecular Sciences
6 publications, 6.9%
Microorganisms
Microorganisms, 4, 4.6%
Microorganisms
4 publications, 4.6%
Pathogens
Pathogens, 4, 4.6%
Pathogens
4 publications, 4.6%
Antibiotics
Antibiotics, 4, 4.6%
Antibiotics
4 publications, 4.6%
Frontiers in Microbiology
Frontiers in Microbiology, 4, 4.6%
Frontiers in Microbiology
4 publications, 4.6%
Molecules
Molecules, 3, 3.45%
Molecules
3 publications, 3.45%
Frontiers in Pharmacology
Frontiers in Pharmacology, 3, 3.45%
Frontiers in Pharmacology
3 publications, 3.45%
Microbiology spectrum
Microbiology spectrum, 3, 3.45%
Microbiology spectrum
3 publications, 3.45%
Pharmaceuticals
Pharmaceuticals, 2, 2.3%
Pharmaceuticals
2 publications, 2.3%
Biomedicines
Biomedicines, 2, 2.3%
Biomedicines
2 publications, 2.3%
Folia Microbiologica
Folia Microbiologica, 2, 2.3%
Folia Microbiologica
2 publications, 2.3%
Scientific Reports
Scientific Reports, 2, 2.3%
Scientific Reports
2 publications, 2.3%
International Journal of Pharmaceutics
International Journal of Pharmaceutics, 2, 2.3%
International Journal of Pharmaceutics
2 publications, 2.3%
Chemistry and Biodiversity
Chemistry and Biodiversity, 2, 2.3%
Chemistry and Biodiversity
2 publications, 2.3%
Infection and Drug Resistance
Infection and Drug Resistance, 2, 2.3%
Infection and Drug Resistance
2 publications, 2.3%
Frontiers in Cellular and Infection Microbiology
Frontiers in Cellular and Infection Microbiology, 2, 2.3%
Frontiers in Cellular and Infection Microbiology
2 publications, 2.3%
Pharmaceutics
Pharmaceutics, 1, 1.15%
Pharmaceutics
1 publication, 1.15%
Diagnostics
Diagnostics, 1, 1.15%
Diagnostics
1 publication, 1.15%
Research on Chemical Intermediates
Research on Chemical Intermediates, 1, 1.15%
Research on Chemical Intermediates
1 publication, 1.15%
Journal of Nanobiotechnology
Journal of Nanobiotechnology, 1, 1.15%
Journal of Nanobiotechnology
1 publication, 1.15%
Annals of Clinical Microbiology and Antimicrobials
Annals of Clinical Microbiology and Antimicrobials, 1, 1.15%
Annals of Clinical Microbiology and Antimicrobials
1 publication, 1.15%
World Journal of Microbiology and Biotechnology
World Journal of Microbiology and Biotechnology, 1, 1.15%
World Journal of Microbiology and Biotechnology
1 publication, 1.15%
Biomaterials Advances
Biomaterials Advances, 1, 1.15%
Biomaterials Advances
1 publication, 1.15%
Results in Chemistry
Results in Chemistry, 1, 1.15%
Results in Chemistry
1 publication, 1.15%
Bioorganic Chemistry
Bioorganic Chemistry, 1, 1.15%
Bioorganic Chemistry
1 publication, 1.15%
Microbial Pathogenesis
Microbial Pathogenesis, 1, 1.15%
Microbial Pathogenesis
1 publication, 1.15%
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 1, 1.15%
European Journal of Medicinal Chemistry
1 publication, 1.15%
Biofilm
Biofilm, 1, 1.15%
Biofilm
1 publication, 1.15%
Process Biochemistry
Process Biochemistry, 1, 1.15%
Process Biochemistry
1 publication, 1.15%
Journal of Photochemistry and Photobiology A: Chemistry
Journal of Photochemistry and Photobiology A: Chemistry, 1, 1.15%
Journal of Photochemistry and Photobiology A: Chemistry
1 publication, 1.15%
1
2
3
4
5
6

Citations by publishers

5
10
15
20
25
30
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 28, 32.18%
Multidisciplinary Digital Publishing Institute (MDPI)
28 publications, 32.18%
Elsevier
Elsevier, 14, 16.09%
Elsevier
14 publications, 16.09%
Springer Nature
Springer Nature, 12, 13.79%
Springer Nature
12 publications, 13.79%
Frontiers Media S.A.
Frontiers Media S.A., 9, 10.34%
Frontiers Media S.A.
9 publications, 10.34%
Wiley
Wiley, 8, 9.2%
Wiley
8 publications, 9.2%
Taylor & Francis
Taylor & Francis, 4, 4.6%
Taylor & Francis
4 publications, 4.6%
American Society for Microbiology
American Society for Microbiology, 4, 4.6%
American Society for Microbiology
4 publications, 4.6%
Dove Medical Press
Dove Medical Press, 2, 2.3%
Dove Medical Press
2 publications, 2.3%
Hindawi Limited
Hindawi Limited, 1, 1.15%
Hindawi Limited
1 publication, 1.15%
American Chemical Society (ACS)
American Chemical Society (ACS), 1, 1.15%
American Chemical Society (ACS)
1 publication, 1.15%
Oxford University Press
Oxford University Press, 1, 1.15%
Oxford University Press
1 publication, 1.15%
Asian Network for Scientific Information, 1, 1.15%
Asian Network for Scientific Information
1 publication, 1.15%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 1, 1.15%
Royal Society of Chemistry (RSC)
1 publication, 1.15%
Future Medicine
Future Medicine, 1, 1.15%
Future Medicine
1 publication, 1.15%
5
10
15
20
25
30
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Cascioferro S. et al. Therapeutic Strategies To Counteract Antibiotic Resistance in MRSA Biofilm‐Associated Infections // ChemMedChem. 2020. Vol. 16. No. 1. pp. 65-80.
GOST all authors (up to 50) Copy
Cascioferro S., Carbone D., Parrino B., Pecoraro C., Giovannetti E., Cirrincione G., Diana P. Therapeutic Strategies To Counteract Antibiotic Resistance in MRSA Biofilm‐Associated Infections // ChemMedChem. 2020. Vol. 16. No. 1. pp. 65-80.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1002/cmdc.202000677
UR - https://doi.org/10.1002%2Fcmdc.202000677
TI - Therapeutic Strategies To Counteract Antibiotic Resistance in MRSA Biofilm‐Associated Infections
T2 - ChemMedChem
AU - Cirrincione, Girolamo
AU - Cascioferro, Stella
AU - Carbone, Daniela
AU - Parrino, Barbara
AU - Pecoraro, Camilla
AU - Giovannetti, Elisa
AU - Diana, Patrizia
PY - 2020
DA - 2020/11/06 00:00:00
PB - Wiley
SP - 65-80
IS - 1
VL - 16
SN - 1860-7179
SN - 1860-7187
ER -
BibTex |
Cite this
BibTex Copy
@article{2020_Cascioferro,
author = {Girolamo Cirrincione and Stella Cascioferro and Daniela Carbone and Barbara Parrino and Camilla Pecoraro and Elisa Giovannetti and Patrizia Diana},
title = {Therapeutic Strategies To Counteract Antibiotic Resistance in MRSA Biofilm‐Associated Infections},
journal = {ChemMedChem},
year = {2020},
volume = {16},
publisher = {Wiley},
month = {nov},
url = {https://doi.org/10.1002%2Fcmdc.202000677},
number = {1},
pages = {65--80},
doi = {10.1002/cmdc.202000677}
}
MLA
Cite this
MLA Copy
Cascioferro, Stella, et al. “Therapeutic Strategies To Counteract Antibiotic Resistance in MRSA Biofilm‐Associated Infections.” ChemMedChem, vol. 16, no. 1, Nov. 2020, pp. 65-80. https://doi.org/10.1002%2Fcmdc.202000677.
Found error?